IL-6 is known to be an NF-κB-dependent cytokine [24,25] and is one of the key cytokines in RA pathogenesis, as evidenced by the fact that an anti-IL-6 receptor monoclonal antibody has been shown to reduce significantly RA disease activity in clinical trials [26]. This evidence concerns the gene IL6 and rheumatoid arthritis.